Network origin in Jan de Witt first degree
Entity | Entity type | Industry | |
---|---|---|---|
Impatients NV
Impatients NV Miscellaneous Commercial ServicesCommercial Services Impatients N.V. operates an online platform for drug innovations. It provides physicians and patients that are excluded from clinical trials access to drugs in development via early access programs. The company was founded by Ronald Brus, SJaak Vink, Govert J. Schouten, Witt Jan, Erdem Yavuz, and René Beukema in 2012 and is headquartered in Amsterdam, the United Kingdom.
5
| Holding Company | Miscellaneous Commercial Services | 5 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Jan de Witt via their personal network
Company | Sector | Related people | Main position |
---|---|---|---|
Janssen Vaccines & Prevention BV
Janssen Vaccines & Prevention BV Pharmaceuticals: MajorHealth Technology Janssen Vaccines & Prevention BV manufactures and supplies biopharmaceutical products. The company was founded in 2000 and is headquartered in Leiden, the Netherlands. | Pharmaceuticals: Major | Chief Executive Officer General Counsel | |
Vu Medical Center
Vu Medical Center Hospital/Nursing ManagementHealth Services Vu Medical Center operates as a hospital. | Hospital/Nursing Management | Corporate Officer/Principal | |
Van Lanschot Kempen NV (Broker)
Van Lanschot Kempen NV (Broker) Investment Banks/BrokersFinance Van Lanschot Kempen NV (Broker) (Van Lanschot Kempen-Broker) is the broker-dealer division of Van Lanschot Kempen NV (AMS: VLK), a financial institution headquartered in Amsterdam, Netherlands. The firm was founded in 1903 and formerly known as Kempen & Co. NV. Van Lanschot Kempen-Broker provides securities broking to institutional investors, companies, financial institutions, (semi) public institutions, foundations and high net-worth individual clients. | Investment Banks/Brokers | Institutional Sales | |
Cristal Delivery BV
Cristal Delivery BV Pharmaceuticals: MajorHealth Technology Cristal Delivery BV develops and manufactures nanomedicines for therapeutic drug optimization. It offers pipeline, oncology, and inflammation programs. The company was founded by Joost J. M. Holthuis and Cristianne Rijcken in April 2011 and is headquartered in Maastricht, the Netherlands. | Pharmaceuticals: Major | Director/Board Member | |
University of Leiden | College/University | Doctorate Degree | |
Frame Pharmaceuticals BV
Frame Pharmaceuticals BV BiotechnologyHealth Technology Part of CureVac NV, Frame Pharmaceuticals BV is a Dutch company that offers cancer therapy services. The company is based in Amsterdam, Netherlands. The company was founded by Ronald Plasterk, Bob Löwenberg. Ronald Plasterk has been the CEO since incorporation. Frame Pharmaceuticals was acquired by CureVac NV on June 08, 2022 for $34.26 million. | Biotechnology | General Counsel | |
Fibriant BV
Fibriant BV Pharmaceuticals: OtherHealth Technology Fibriant BV is a Dutch biotechnology company that specializes in the recombinant manufacturing and characterization of specific variants of human Fibrinogen and active human Thrombin. The company is based in Leiden, the Netherlands. The company's science and technology are centered around Fibrinogen, a soluble blood protein that can be converted into an insoluble three-dimensional Fibrin network. Fibriant captures the unique features and functions of specific recombinant variants of Fibrinogen in new innovative products and in improvements of existing products based on plasma Fibrinogen. The company was founded in 2015 by Jaap Koopman, Jos Grimbergen, Miranda Weggeman, and Jaap Koopman has been the CEO since then. | Pharmaceuticals: Other | Director/Board Member | |
Radboud University Nijmegen | College/University | Doctorate Degree | |
PROQR THERAPEUTICS N.V. | Pharmaceuticals: Major | Director/Board Member | |
University of Groningen | College/University | Doctorate Degree | |
Aescap Venture Management BV
Aescap Venture Management BV Investment ManagersFinance Aescap Venture Management BV is an independent venture capital investment firm based in Amsterdam. Aescap was founded in 2005 by Michiel de Haan and Dinko Valerio. Inspired by the name of the Greek god of healthcare, Aesculapiu, the firm's name is an acronym for 'Accelerating European Science Companies and Products.' The firm focuses on developing growth in European firms in the biomedical sector. | Investment Managers | Private Equity Investor | |
GE Capital Europe Ltd.
GE Capital Europe Ltd. Finance/Rental/LeasingFinance GE Capital Europe Ltd. provides consumer financing services. It offers accounts receivable, financing, consumer, equipment and healthcare finance solutions. The firm provides industry specific expertise in aviation, energy, infrastructure, healthcare, and media to capitalize on market-specific opportunities. The company is headquartered in London, the United Kingdom. | Finance/Rental/Leasing | General Counsel | |
University of Amsterdam | College/University | Graduate Degree | |
Leyden Laboratories B.V.
Leyden Laboratories B.V. Miscellaneous Commercial ServicesCommercial Services Leyden Laboratories B.V. is a biotechnology company based in Amsterdam, Netherlands. Leyden Labs aims to protect humanity from known and future viruses by targeting commonalities of viral families. The Dutch company has developed a portfolio of accessible intranasal product candidates that may provide people with the freedom to immediately protect themselves from and prevent the spread of many strains of respiratory viruses, including ones in the influenza and coronavirus families. The company's energetic team of world-renowned biotechnology veterans and fresh talent is dedicated to thinking differently to free humanity from the burden of respiratory viruses. Leyden Labs is backed with $200m by blue-chip investors Casdin Capital, GV (formerly Google Ventures), F-Prime Capital, Byers Capital/Brook Byers, SoftBank Investment Advisers, Invus, and Bluebird Ventures. The company was founded in June 2020 by Koenraad Wiedhaup, Jaap Goudsmit, Domenico Valerio, and Ronald H. P. Brus, with Koenraad Wiedhaup serving as the CEO since incorporation. | Miscellaneous Commercial Services | Founder | |
Zambon Nederland BV
Zambon Nederland BV Pharmaceuticals: MajorHealth Technology Zambon Nederland BV operates as a pharmaceutical company. The company was founded in 1906 and is headquartered in Amersfoort, the Netherlands. | Pharmaceuticals: Major | Corporate Officer/Principal | |
GALAPAGOS NV | Biotechnology | Director/Board Member | |
The Social Medwork BV
The Social Medwork BV Medical DistributorsDistribution Services The Social Medwork BV provides medicines. It offers medicines for oncology, neurology, dermatology, hepatology, infectology, pulmonology and rheumatology. The company was founed by Sjaak Vink and is headquartered in Amsterdam, the Netherlands. | Medical Distributors | Chief Executive Officer |
Statistics
International
Netherlands | 20 |
United Kingdom | 3 |
Belgium | 2 |
Sectoral
Health Technology | 10 |
Consumer Services | 5 |
Finance | 4 |
Commercial Services | 3 |
Transportation | 3 |
Operational
General Counsel | 8 |
Founder | 7 |
Corporate Officer/Principal | 7 |
Chief Executive Officer | 5 |
Director/Board Member | 4 |
Most connected contacts
Insiders | |
---|---|
René Beukema | 13 |
Ronald H. P. Brus | 7 |
Govert J. Schouten | 6 |
Erdem Yavuz | 2 |
Sjaak Vink | 2 |
- Stock Market
- Insiders
- Jan de Witt
- Company connections